Core Points - The article reports that Cai Dongchen, the executive director and chairman of CSPC Pharmaceutical Group (01093.HK), increased his shareholding by purchasing 3 million shares at an average price of HKD 8.81 per share, totaling approximately HKD 26.43 million [1] - Following this transaction, Cai's total shareholding increased to 2,842,118,670 shares, raising his ownership percentage from 24.64% to 24.67% [1] Summary by Sections - Share Purchase Details - Cai Dongchen acquired 3 million shares at an average price of HKD 8.81 per share [1] - The total investment for this purchase was about HKD 26.43 million [1] - Shareholding Changes - After the purchase, Cai's total shares held reached 2,842,118,670 [1] - His ownership percentage increased from 24.64% to 24.67% [1]
石药集团(01093.HK)获执行董事兼主席蔡东晨增持300万股